68 Biggest Movers From Yesterday
Gainers
Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday.
ANI Pharma’s Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus
ANI Pharmaceuticals Inc’s (NASDAQ:ANIP) Q4 revenues were $60.9 million, +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for…
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.
ANI Pharmaceuticals Announces Commercial Availability Of Purified Cortrophin Gel For Multiple Chronic Autoimmune Disorders
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced the U.S. commercial availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) 80 U/mL. The commercial launch of
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
Here's a roundup of top developments in the biotech space over the last 24 hours:
Eton Pharmaceuticals And ANI Pharmaceuticals Announce Commercial Availability Of Carglumic Acid Tablets, The First And Only FDA-Approved Generic Version Of Carbaglu
Product is now available exclusively through Anovo specialty pharmacy
Product is stable at room temperature while Carbaglu® requires refrigeration
Eton Cares patient support program will
ANI Pharmaceuticals Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of Novitium Pharma
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted the proposed consent order in connection with ANI's definitive agreement to